| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/30/2007 | EP1789066A1 Compositions and methods of using alpha-fetoprotein growth inhibitory peptides |
| 05/30/2007 | EP1789031A2 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 05/30/2007 | EP1789019A2 Powders containing novel oligosaccharide mixtures and methods for producing the same |
| 05/30/2007 | EP1531797A4 Biodegradable block copolymeric compositions for drug delivery |
| 05/30/2007 | EP1496925A4 Use of interleukin-24 to treat ovarian cancer |
| 05/30/2007 | EP1496924A4 Treatment of gastroparesis |
| 05/30/2007 | EP1492878B1 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 05/30/2007 | EP1492560A4 Use of interleukin-19 to treat cervical cancer |
| 05/30/2007 | EP1482858A4 Methods for aneurysm repair |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP1373487B1 Regulation of human protein kinase-like protein |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1294356B1 Sustained release delivery systems for solutes |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP1206274B1 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP1171165B1 Intramyocardial injection of autologous bone marrow |
| 05/30/2007 | EP1107791B1 Hydrogel compositions for the controlled release administration of growth factors |
| 05/30/2007 | EP1070758B1 Human stanniocalcin and uses thereof to inhibit adipogenesis |
| 05/30/2007 | EP1019010B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0904367B1 Scf analog compositions and methods |
| 05/30/2007 | EP0811383B1 Remedies for arthrosis deformans and inflammatory joint diseases |
| 05/30/2007 | EP0729975B9 Ecdn protein and dna coding for the same |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | CN1973053A Novel anti-IL 13 antibodies and uses thereof |
| 05/30/2007 | CN1973042A Process for producing dipeptides |
| 05/30/2007 | CN1973040A EphA4 as therapeutic target of PRC and PDACa |
| 05/30/2007 | CN1973037A Process for producing dipeptides or dipeptide derivatives |
| 05/30/2007 | CN1972957A Potassium channel regulating pepetide |
| 05/30/2007 | CN1972956A Novel compounds as inhibitors of hepatitis c virus NS3 serine protease |
| 05/30/2007 | CN1972709A Treatment method of non alcoholic steatotic hepatitis (NASH) |
| 05/30/2007 | CN1972708A Compositions for topical treatment |
| 05/30/2007 | CN1972707A Treatment of conditions involving demyelination |
| 05/30/2007 | CN1972706A Malignant tumor-inhibiting preparation comprising des A fibrin |
| 05/30/2007 | CN1972705A Use of sulglicotide for the treatement of mucositis |
| 05/30/2007 | CN1972704A Anti-aging effects of substance P |
| 05/30/2007 | CN1972703A Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors |
| 05/30/2007 | CN1972699A Agent for substitution of blood plasma and a method of its production |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1970774A Porcine alpha-interferon recombinant adenovirus and its construction method and application |
| 05/30/2007 | CN1970773A Novel recombinant plasmid for expression of blood coagulation factor 8 in mammal cell |
| 05/30/2007 | CN1970764A Porcine beta-interferon recombinant adenovirus and its construction method and application |
| 05/30/2007 | CN1970746A Bifunctional variants of recombinant tissue-type plasminogen activator with platelet aggregation inhibitory activity |
| 05/30/2007 | CN1970574A Double function infusion protein for thrombolysis and anticoagulation , its preparation method and uses |
| 05/30/2007 | CN1970572A Interferon alpha mutant and its polyethylene glycol derivative |
| 05/30/2007 | CN1970571A G-csf analog compositions and methods |
| 05/30/2007 | CN1970570A Yeast engineered bacteria for expressing recombinant prawn protein Pen9 and its preparation method and uses |
| 05/30/2007 | CN1970086A Monomodified PEGylated insulin and its preparation method |
| 05/30/2007 | CN1970085A Orally disintegrating tablet of ubenimex and preparation method thereof |
| 05/30/2007 | CN1970079A Vagina effervescence tablet of recombinant human interferon alpha-2a and preparation process thereof |
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970076A Method for preparing colon targeted pill of polymyxin B sulfate used for poultry and livestock |
| 05/30/2007 | CN1970075A Lyophilized powder injection of glutathione and preparation process thereof |
| 05/30/2007 | CN1970074A Application of beta-protein inhibitor in preparation of medicament for treating genetic correlated disease |
| 05/30/2007 | CN1969616A Method for constructing allotetraploid of bluntsnout bream |
| 05/30/2007 | CN1318594C Recombinant human VEGF and bFGF eukaryon expression vector, fused protein and applications thereof |
| 05/30/2007 | CN1318591C Immune tbid gene and its coded protein and application |
| 05/30/2007 | CN1318590C Human protooncogene KG-20 and protein encoded therein |
| 05/30/2007 | CN1318589C Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 05/30/2007 | CN1318588C Osteoprotegerine |
| 05/30/2007 | CN1318586C Method for the in vitro synthesis of short double stranded RNAs |
| 05/30/2007 | CN1318576C Targeted cytolysis of HIV-infected cells by chimerical CD4 receptor bearing cells |
| 05/30/2007 | CN1318450C Modified/chimeric super-antigens and their use |
| 05/30/2007 | CN1318448C Recombined full length human brain red element, preparation method and application thereof |
| 05/30/2007 | CN1318447C Tumor antigen peptides originating in cyclophilin B |
| 05/30/2007 | CN1318092C Immunity treatment composition containing antibody-cytokine fusion protein mediated and angiogenesis inhibitor |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318090C Medicine composition for improving stability of human urine kininogenase |
| 05/30/2007 | CN1318089C Use of botulinum toxin for treatment of articular pathologies |
| 05/30/2007 | CN1318088C Oral cavity plastering sheet of interferon and its preparation method |
| 05/30/2007 | CN1318087C Removing albumin nerve growth factor agent |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318085C Ossotide injection and preparation method thereof |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/30/2007 | CN1318029C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1, 2, 3-triazoles |
| 05/30/2007 | CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/29/2007 | WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 05/29/2007 | US7225083 Determination antagonist, moderators; three-dimensional models |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223856 Therapy for nervous system degradation |
| 05/29/2007 | US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis |
| 05/29/2007 | US7223853 Secreted frizzled related protein fragments |
| 05/29/2007 | US7223852 Nucleic acids encoding TRAIN-R: a cysteine rich member of the TNF-receptor family |
| 05/29/2007 | US7223849 For inhibiting neoplastic cell growth in a human or mouse |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223845 Which have one or more sulfated tyrosine residues and a glycan linked to the peptide, the glycan preferably including a sialyl Lewisx group or a sialyl Lewisa group; antiinflammatory, antithrombotic, antimetastatic compounds |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223837 Anticancer prodrugs, enhance enzymatic activation rates |
| 05/29/2007 | US7223836 Peptides for chlamydophila pneumoniae vaccine and diagnosis |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223834 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
| 05/29/2007 | US7223790 Dimeric compounds and their use as anti-viral agents |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223748 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 05/29/2007 | US7223743 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/29/2007 | US7223740 isolated host cell; treatment of arterial diseases, comprising intramuscularly administering a vector |
| 05/29/2007 | US7223736 Composition for the prevention and treatment of cachexia |
| 05/29/2007 | US7223735 Abuse resistant lysine amphetamine compounds |